Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

PharmaCyte Biotech, Inc. PMCB

Full chart Compare
Set alert

Price alert · PMCB

All alert types
0.38 USD +0.04 (+12.03%)

At closeNov 4, 2026, 5:39 PM EST

0.39 +0.01 +2.36%

After hours · Nov 4, 5:39 PM ET

0.337 Day range 0.42
0.3021 52-week range 1.51
YTD
-47.38%
1 year
-57.19%

Revenue & Expenses

Other Income → Expenses: $240.68KExpenses → Selling, General & Admin: $1.69MExpenses → Interest Expense: $154.42KGross Profit → Expenses: $2.54KRevenue → Gross Profit: $2.54KRevenue → Cost of Revenue: $9.62KNet Loss → Expenses: $1.60MOther Income$240.68KGross Profit$2.54KNet Loss$1.60MCost of Revenue$9.62KExpenses$1.84MSelling, General & Admin$1.69MInterest Expense$154.42KRevenue$12.16K

Latest period ending Apr 30, 2026 · select a line to chart its full history

Income statement

Full income statement How to read it
PMCB annual income statement
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
-6.85M-4.38M-8.52M-6.46M-4.39M
-19.42M30.66M333.76K-4.32M-4.24M
-2.773.19-1.80-0.22-0.27

Balance sheet

Full balance sheet How to read it
PMCB annual balance sheet
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
18.60M15.17M50.18M68.04M85.40M
46.75M55.17M59.90M73.28M90.62M
11.77M3.28M20.39M586.58K704.37K
33.29M51.89M27.65M72.69M89.92M

Cash flow

Full cash flow How to read it
PMCB annual cash flow
Fiscal yearFY 2026 Apr 30, 2026FY 2025 Apr 30, 2025FY 2024 Apr 30, 2024FY 2023 Apr 30, 2023FY 2022 Apr 30, 2022
-5.15M-2.98M-2.15M-3.79M-4.12M
2.00M-7.00M-5.00M00
6.58M-25.03M-10.71M-13.56M87.31M
3.43M-35.01M-17.86M-17.36M83.20M